The Asia Pacific Genomics Market is expected to witness market growth of 17.6% CAGR during the forecast period (2021-2027).
One of the important drivers driving the market's growth is the growing use of non-invasive cancer screening-based research, as well as the growing need for tailored treatments. Moreover, the increasing prevalence of chronic disorders will increase the demand for gene-based treatments.
Clinical workflows are increasingly being combined with genomic data in order to develop targeted and personalized treatments, as well as to analyze the growth of newborn genetic screening programs and military genomics. Furthermore, an increase in demand for genetically modified plants and creatures in the agricultural sector is boosting market growth.
Another key growth-inducing aspect is technology improvements, such as the creation of genomics-based apps and testing. Other factors, such as substantial bioinformatics research and development (R&D) activities and rising demand for next-generation sequencing services, are expected to propel the market even further.
Due to increased demand for genetic sequencing and testing in China and developments in bioinformatics, Asia Pacific is expected to witness new demand for genomics. Moreover, the market is being propelled forward by rising demand for the development of medications for rare diseases, as well as technology advancements such as the combination of next-generation sequencing and companion diagnostics in this space. Hence, these factors are anticipated to fuel the growth of the regional Genomics Market during the forecasting period.
The China market dominated the Asia Pacific Genomics Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $5,180.1 million by 2027. The Japan market is poised to grow a CAGR of 16.8% during (2021 - 2027). Additionally, The India market is expected to witness a CAGR of 18.3% during (2021 - 2027).
Based on Product & Service, the market is segmented into Consumables, Systems & Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Diagnostics, Agriculture & Animal Research and Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies and Others. Based on Technology, the market is segmented into Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Creative Biogene, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Eurofins Scientific Group, Qiagen N.V., and New England BioLabs, Inc.
One of the important drivers driving the market's growth is the growing use of non-invasive cancer screening-based research, as well as the growing need for tailored treatments. Moreover, the increasing prevalence of chronic disorders will increase the demand for gene-based treatments.
Clinical workflows are increasingly being combined with genomic data in order to develop targeted and personalized treatments, as well as to analyze the growth of newborn genetic screening programs and military genomics. Furthermore, an increase in demand for genetically modified plants and creatures in the agricultural sector is boosting market growth.
Another key growth-inducing aspect is technology improvements, such as the creation of genomics-based apps and testing. Other factors, such as substantial bioinformatics research and development (R&D) activities and rising demand for next-generation sequencing services, are expected to propel the market even further.
Due to increased demand for genetic sequencing and testing in China and developments in bioinformatics, Asia Pacific is expected to witness new demand for genomics. Moreover, the market is being propelled forward by rising demand for the development of medications for rare diseases, as well as technology advancements such as the combination of next-generation sequencing and companion diagnostics in this space. Hence, these factors are anticipated to fuel the growth of the regional Genomics Market during the forecasting period.
The China market dominated the Asia Pacific Genomics Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $5,180.1 million by 2027. The Japan market is poised to grow a CAGR of 16.8% during (2021 - 2027). Additionally, The India market is expected to witness a CAGR of 18.3% during (2021 - 2027).
Based on Product & Service, the market is segmented into Consumables, Systems & Software and Services. Based on Application, the market is segmented into Drug Discovery & Development, Diagnostics, Agriculture & Animal Research and Others. Based on End User, the market is segmented into Hospitals & Clinics, Research Centers and Academic & Government Institutes, Pharmaceutical & Biotechnology Companies and Others. Based on Technology, the market is segmented into Sequencing, PCR, Nucleic Acid Extraction & Purification, Microarray, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Creative Biogene, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Eurofins Scientific Group, Qiagen N.V., and New England BioLabs, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product & Service
- Consumables
- Systems & Software and
- Services
By Application
- Drug Discovery & Development
- Diagnostics
- Agriculture & Animal Research and
- Others
By End User
- Hospitals & Clinics
- Research Centers and Academic & Government Institutes
- Pharmaceutical & Biotechnology Companies and
- Others
By Technology
- Sequencing
- PCR
- Nucleic Acid Extraction & Purification
- Microarray, and
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Creative Biogene
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Hoffmann-La Roche Ltd.
- Eurofins Scientific Group
- Qiagen N.V.
- New England BioLabs, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Genomics Market by Product & Service
Chapter 5. Asia Pacific Genomics Market by Application
Chapter 6. Asia Pacific Genomics Market by End User
Chapter 7. Asia Pacific Genomics Market by Technology
Chapter 8. Asia Pacific Genomics Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Creative Biogene
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Eurofins Scientific Group
- Qiagen N.V.
- New England BioLabs, Inc.
Methodology
LOADING...
